President Trump nominated White House domestic policy aide Dr. Heidi Overton on August 19, 2026, to serve as FDA commissioner following the May resignation of Dr. Marty Makary. The Senate Health, Education, Labor and Pensions Committee must first advance the nomination before a full Senate vote. Committee chairman Sen. Bill Cassidy voiced immediate strong reservations over Overton’s involvement in a recent executive order on childhood vaccines, describing it as nearly disqualifying and signaling potential hurdles even among Republicans. Democratic members, including Sen. Patty Murray, have signaled opposition. Confirmation would require navigating committee scrutiny and securing sufficient Republican support in a process that can shift with additional statements or hearing developments.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · Обновлено$14,094 Объем
30 сентября
21%
31 октября
35%
30 ноября
36%
31 декабря
40%
$14,094 Объем
30 сентября
21%
31 октября
35%
30 ноября
36%
31 декабря
40%
If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”.
The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution.
The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.
Открытие рынка: Aug 20, 2026, 5:43 PM ET
Resolver
0x65070BE91...If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”.
The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution.
The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.
Resolver
0x65070BE91...President Trump nominated White House domestic policy aide Dr. Heidi Overton on August 19, 2026, to serve as FDA commissioner following the May resignation of Dr. Marty Makary. The Senate Health, Education, Labor and Pensions Committee must first advance the nomination before a full Senate vote. Committee chairman Sen. Bill Cassidy voiced immediate strong reservations over Overton’s involvement in a recent executive order on childhood vaccines, describing it as nearly disqualifying and signaling potential hurdles even among Republicans. Democratic members, including Sen. Patty Murray, have signaled opposition. Confirmation would require navigating committee scrutiny and securing sufficient Republican support in a process that can shift with additional statements or hearing developments.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · Обновлено



Не доверяй внешним ссылкам.
Не доверяй внешним ссылкам.
Часто задаваемые вопросы